Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Inventory (2016 - 2025)

CorMedix has reported Inventory over the past 11 years, most recently at $29.7 million for Q4 2025.

  • Quarterly results put Inventory at $29.7 million for Q4 2025, up 2760.06% from a year ago — trailing twelve months through Dec 2025 was $29.7 million (up 2760.06% YoY), and the annual figure for FY2025 was $29.7 million, up 2760.06%.
  • Inventory reached $29.7 million in Q4 2025 per CRMD's latest filing, up from $9.2 million in the prior quarter.
  • Across five years, Inventory topped out at $29.7 million in Q4 2025 and bottomed at $269.0 in Q3 2022.
  • Median Inventory over the past 5 years was $1.1 million (2024), compared with a mean of $3.4 million.
  • The largest annual shift saw Inventory crashed 99.45% in 2022 before it soared 2760.06% in 2025.
  • Over 5 years, Inventory stood at $3008.0 in 2021, then plummeted by 91.06% to $269.0 in 2022, then skyrocketed by 782927.88% to $2.1 million in 2023, then crashed by 50.67% to $1.0 million in 2024, then skyrocketed by 2760.06% to $29.7 million in 2025.
  • Business Quant data shows Inventory for CRMD at $29.7 million in Q4 2025, $9.2 million in Q3 2025, and $2.6 million in Q2 2025.